Literature DB >> 11819612

Polymorphism of p16INK4a gene and rare mutation of p15INK4b gene exon2 in primary hepatocarcinoma.

Yang Qin, Bo Li, Yong-Shu Tan, Zhi-Lin Sun, Feng-Qiong Zuo, Ze-Fang Sun.   

Abstract

Entities:  

Year:  2000        PMID： 11819612      PMCID： PMC4688766          DOI： 10.3748/wjg.v6.i3.411

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  16 in total

1.  Role of the INK4a locus in tumor suppression and cell mortality.

Authors:  M Serrano; H Lee; L Chin; C Cordon-Cardo; D Beach; R A DePinho
Journal:  Cell       Date:  1996-04-05       Impact factor: 41.582

2.  Inactivation of p16INK4 in hepatocellular carcinoma.

Authors:  A M Hui; M Sakamoto; Y Kanai; Y Ino; M Gotoh; J Yokota; S Hirohashi
Journal:  Hepatology       Date:  1996-09       Impact factor: 17.425

3.  Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers.

Authors:  T Nobori; K Miura; D J Wu; A Lois; K Takabayashi; D A Carson
Journal:  Nature       Date:  1994-04-21       Impact factor: 49.962

4.  Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma.

Authors:  T Mori; K Miura; T Aoki; T Nishihira; S Mori; Y Nakamura
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

5.  CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.

Authors:  E E Schmidt; K Ichimura; G Reifenberger; V P Collins
Journal:  Cancer Res       Date:  1994-12-15       Impact factor: 12.701

6.  Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers.

Authors:  S Yoshida; T Todoroki; Y Ichikawa; S Hanai; H Suzuki; M Hori; K Fukao; M Miwa; K Uchida
Journal:  Cancer Res       Date:  1995-07-01       Impact factor: 12.701

7.  Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers.

Authors:  M R Rusin; A Okamoto; M Chorazy; K Czyzewski; J Harasim; E A Spillare; K Hagiwara; S P Hussain; Y Xiong; D J Demetrick; C C Harris
Journal:  Int J Cancer       Date:  1996-03-15       Impact factor: 7.396

8.  p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest.

Authors:  G J Hannon; D Beach
Journal:  Nature       Date:  1994-09-15       Impact factor: 49.962

9.  Deletion of the p16 and p15 genes in human bladder tumors.

Authors:  I Orlow; L Lacombe; G J Hannon; M Serrano; I Pellicer; G Dalbagni; V E Reuter; Z F Zhang; D Beach; C Cordon-Cardo
Journal:  J Natl Cancer Inst       Date:  1995-10-18       Impact factor: 13.506

10.  Mutational analysis of the p15 and p16 genes in acute leukaemias.

Authors:  H Sill; R C Aguiar; H Schmidt; A Hochhaus; J M Goldman; N C Cross
Journal:  Br J Haematol       Date:  1996-03       Impact factor: 6.998
View more
  15 in total

1.  Effect of 5-Aza-2'-deoxycytidine on the P16 tumor suppressor gene in hepatocellular carcinoma cell line HepG2.

Authors:  L H Liu; W H Xiao; W W Liu
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Methylation status of c-fms oncogene in HCC and its relationship with clinical pathology.

Authors:  J Cui; D H Yang; X J Bi; Z R Fan
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

3.  Expression, deletion [was deleton] and mutation of p16 gene in human gastric cancer.

Authors:  X S He; Q Su; Z C Chen; X T He; Z F Long; H Ling; L R Zhang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

4.  Mutation of RET gene in Chinese patients with Hirschsprung's disease.

Authors:  Ji-Cheng Li; Shi-Ping Ding; Ying Song; Min-Ju Li
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

5.  Preparation of monoclonal antibody against apoptosis-associated antigens of hepatoma cells by subtractive immunization.

Authors:  Lian-Jun Yang; Wen-Liang Wang
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

6.  P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection.

Authors:  Lun-Xiu Qin; Zhao-You Tang; Zeng-Chen Ma; Zhi-Quan Wu; Xin-Da Zhou; Qing-Hai Ye; Yuan Ji; Li-Wen Huang; Hu-Liang Jia; Hui-Chuan Sun; Lu Wang
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

7.  Tumor suppressor gene p16 and Rb expression in gastric cardia precancerous lesions from subjects at a high incidence area in northern China.

Authors:  Yun Zhou; Shan-Shan Gao; Yong-Xin Li; Zong-Min Fan; Xin Zhao; Yi-Jun Qi; Jun-Ping Wei; Jian-Xiang Zou; Gang Liu; Li-Huo Jiao; Yong-Min Bai; Li-Dong Wang
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

8.  The analysis of gamma-glutamyl transpeptidase gene in different type liver tissues.

Authors:  Guo-Qing Han; Cheng-Yong Qin; Rong-Hua Shu
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

9.  Somatic mutation analysis of p53 and ST7 tumor suppressor genes in gastric carcinoma by DHPLC.

Authors:  Chong Lu; Hui-Mian Xu; Qun Ren; Yang Ao; Zhen-Ning Wang; Xue Ao; Li Jiang; Yang Luo; Xue Zhang
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

10.  Association of low p16INK4a and p15INK4b mRNAs expression with their CpG islands methylation with human hepatocellular carcinogenesis.

Authors:  Yang Qin; Jian-Yu Liu; Bo Li; Zhi-Lin Sun; Ze-Fang Sun
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.